Canada Markets close in 4 hrs 49 mins

Gritstone bio, Inc. (GRTS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.2000-0.0200 (-0.62%)
As of 11:10AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close3.2200
Open3.1800
Bid3.1600 x 800
Ask3.1700 x 1000
Day's Range3.1400 - 3.2250
52 Week Range1.7100 - 6.1000
Volume100,493
Avg. Volume1,177,709
Market Cap217.561M
Beta (5Y Monthly)0.56
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    EMERYVILLE, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the company’s Board of Directors granted two employees nonqualified stock options to purchase an aggregate of 28,000 shares of its common stock with an exercise price of $3.67, which is equal to the closing price of Gritstone’s common stock on January 9, 2023, the date of the grant. These stock

  • GlobeNewswire

    Gritstone bio to Participate in Upcoming Investor Conferences

    EMERYVILLE, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will participate in the following investor conferences. B. Riley Securities' 3rd Annual Oncology Conference (Fireside Chat)Date and Time: Thursday, January 19, 2023 at 12:30pm ETPresenter: Andrew Allen, M.D., Ph.D., Co-founder, President, and Chief Executive Officer 2023 BIO CEO & Inve

  • GlobeNewswire

    Gritstone bio to Present at 41st Annual J.P. Morgan Healthcare Conference

    EMERYVILLE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that Andrew Allen, M.D., Ph.D., Co-founder, President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference occurring January 9-12, 2023 in San Francisco. The presentation will take place on Thursday, January 12, 2023 from 9:45 - 10:25 AM Pacific Time in Elizab